RxDoctor Payments Data

Timothy Vachris

Sports Medicine · Austin, TXNPI 1285872143

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Gilead. That places this record below the midpoint for sports medicine clinicians in TX, where the typical reported total is $1,700.

$44in general payments, 2019–2025

Across 3 payments — averaging $14.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$44
$5,714,445in research payments, 2019–2025

Across 75,288 payments — averaging $75.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$4.9M
  • Janssen Research & Development, LLC$363K
  • Merck$362K
  • AstraZeneca$44K
  • Pfizer$25K
  • Dynavax Technologies Corporation$6K

What the payments were for

  • Food & beverage$44100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead3$44

How this compares

$44 in reported general payments places this provider in the 5th percentile of 437 sports medicine providers in Texas.

See all sports medicine providers in Texas →

Other sports medicine in Austin

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →